AGIOS PHARMACEUTICALS, INC. Item 5.07 Submission of Matters to a Vote of Security Holders.
1. The Company's stockholders elected Paul J. Clancy and Ian T. Clark as
class I directors, each to serve for a three-year term expiring at the
2023 Annual Meeting of Stockholders and until his successor has been duly
elected and qualified. The results of the stockholders' vote with respect
to the election of such class I directors were as follows:
Votes Broker
Votes For Withheld Non-Votes
Paul J. Clancy 60,670,901 857,420 2,034,778
Ian T. Clark 47,086,910 14,441,411 2,034,778
2. The Company's stockholders approved the non-binding, advisory vote on the
compensation paid to its named executive officers. The results of the
stockholders' non-binding, advisory vote with respect to compensation paid
to the Company's named executive officers were as follows:
Votes Votes Broker
Votes For Against Abstaining Non-Votes
40,178,904 21,338,059 11,358 2,034,778
3. The Company's stockholders ratified the appointment of
PricewaterhouseCoopers LLP as the Company's independent registered public
accounting firm for the current fiscal year. The results of the
stockholders' vote with respect to such ratification were as follows:
Votes Votes Broker
Votes For Against Abstaining Non-Votes
63,500,010 56,127 6,962 0
--------------------------------------------------------------------------------
© Edgar Online, source
